177Lu-BetaBart
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 177Lu-BetaBart, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors [Phase 1, Phase 2]